Summary
UnitedHealth Group Inc. (UNH) filed an 8-K on January 20, 2011, to announce its fourth quarter and full year 2010 financial results. The report primarily references a press release detailing these results, highlighting a significant charge impacting the Ingenix segment. Specifically, Ingenix incurred $200 million in goodwill impairment and business line disposition charges, which led to a reported net loss from operations of $(99) million for the fourth quarter and a reduced operating margin of (13.8%) for the same period. Excluding these charges, adjusted earnings and margins were presented as non-GAAP measures. For the full year 2010, these charges reduced Ingenix's earnings from operations to $84 million and its operating margin to 3.6%. Investors should note that these figures are specifically for the Ingenix segment and are subject to goodwill impairment and disposition impacts. The company provided a reconciliation to GAAP measures for these non-GAAP figures. While the 8-K itself doesn't provide comprehensive financial statements, it directs investors to the accompanying press release for detailed financial performance and analysis.
Key Highlights
- 1Announcement of Q4 and Full Year 2010 financial results via press release.
- 2Ingenix segment incurred $200 million in goodwill impairment and business line disposition charges.
- 3Ingenix reported a Q4 2010 loss from operations of $(99) million and an operating margin of (13.8%) due to these charges.
- 4Full Year 2010 Ingenix earnings from operations were $84 million, with an operating margin of 3.6%, impacted by the charges.
- 5Company provided non-GAAP financial measures, excluding the Ingenix charges, for adjusted earnings and operating margin.
- 6A reconciliation between GAAP and non-GAAP measures for Ingenix is available in the referenced press release.
- 7The 8-K filing incorporates the press release by reference as Exhibit 99.1.